In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
400 News Items found
3D illustration of a heart
Q&A
Breast Cancer Treatment and the Risk of Heart Disease: What to Know

The American Heart Association recently issued a statement about the risk of cardiovascular disease for women with breast cancer.
A chess match
In the Lab
Resistance Is Futile: Targeted Treatment Makes Stubborn Cancers Responsive to Immunotherapy

New research on an experimental drug provides hope for better responses to immunotherapy.
Scanning electron micrograph (SEM) of T lymphocyte cells (blue) attached to a red cancer cell.
Finding
Discovery of Unusual Cell Type Could Help Guide Immunotherapy

A newly identified group of immunosuppressive cells could provide insight into the effects of immunotherapy drugs.
Sisters Jo and Jan Claire Luzarraga are seen smiling.
MSK’s Expertise in Caring for Younger Adults With Cancer

Learn about MSK's expertise and compassion in caring for people under 50 who are facing cancer.
Joan Massagué leads Memorial Sloan Kettering's Metastasis Research Center
Opening Cancer's Black Box

The Metastasis Research Center has brought together 27 Memorial Sloan Kettering laboratories to facilitate research on metastasis and its treatment.
Close up photo of three pill types
Q&A
What's Become of AIDS-Related Cancers?

Several types of cancer were once strongly linked to an AIDS diagnosis. Thanks to improved HIV medications, that's changing.
How MSK Is Improving CAR-T Cell Therapy for Cancer Treatment
How MSK Is Improving CAR T Cell Therapy for Cancer Treatment

Learn how experts at MSK who helped develop CAR T cell therapy to fight cancer are making the treatment stronger, safer, more durable and accessible to more people.
fluorescent cells
Small Number of ‘Highly Plastic’ Cancer Cells Drive Disease Progression and Treatment Resistance

A small number of cancer cells with the ability to change their identities and behaviors appear to be a key driver of cancer progression and its ability to evolve resistance to treatment, MSK researchers have found in a laboratory study of lung cancer.
Dr. Shanu Modi speaks with a patient
In the Clinic
FDA Approves Trastuzumab Deruxtecan (T-DXd) for Early-Stage HER2-Positive Breast Cancer

The FDA has approved trastuzumab deruxtecan (T-DXd, Enhertu) for treating early-stage, HER2-positive breast cancer based in part on clinical research led by MSK breast medical oncologist Shanu Modi, MD.
MSK Surgeon Aimee Crago
In the Clinic
How Research Is Driving the Latest Treatments for Sarcoma

Surgeon and researcher Aimee Crago discusses the latest treatments for different types of soft tissue sarcoma, including liposarcoma and desmoid tumors.